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Loss of ubiquitin E2 Ube2w rescues 
hypersensitivity of Rnf4 mutant 
cells to DNA damage
Jean-François Maure1, Sandra C. Moser1, Ellis G. Jaffray1, Arno F. Alpi2 & Ronald T. Hay1
SUMO and ubiquitin play important roles in the response of cells to DNA damage. These pathways are 
linked by the SUMO Targeted ubiquitin Ligase Rnf4 that catalyses transfer of ubiquitin from a ubiquitin 
loaded E2 conjugating enzyme to a polySUMO modified substrate. Rnf4 can functionally interact with 
multiple E2s, including Ube2w, in vitro. Chicken cells lacking Rnf4 are hypersensitive to hyroxyurea, 
DNA alkylating drugs and DNA crosslinking agents, but this sensitivity is suppressed by simultaneous 
depletion of Ube2w. Cells depleted of Ube2w alone are not hypersensitive to the same DNA damaging 
agents. Similar results were also obtained in human cells. These data indicate that Ube2w does not have 
an essential role in the DNA damage response, but is deleterious in the absence of Rnf4. Thus, although 
Rnf4 and Ube2w functionally interact in vitro, our genetic experiments indicate that in response to DNA 
damage Ube2w and Rnf4 function in distinct pathways.
The failure to properly correct DNA damage is thought to be a major driving force in the development of cancer 
and ageing. Familial backgrounds carrying mutations in genes involved in DNA damage repair pathways often 
produce offspring which develop syndromes with severe brain malformation and/or tumour predisposition1. 
The most common type of DNA lesions is the loss or modification of a single base or nucleotide which occurs at 
104–105/cell per day2,3. Direct nucleotide modifications are repaired by Base Excision Repair (BER) and 
Nucleotide Excision Repair (NER). One of the most hazardous types of DNA damage is when both strands of 
the DNA double helix are broken. DNA double strand breaks are mostly processed by two repair pathways: 
homologous recombination (HR) and non-homologous end joining (NHEJ). NHEJ is the predominant repair 
pathway in human cells and represents the rejoining, by blunt end ligation, of the two double strand ends of DNA 
generated by the break. As the broken ends are susceptible to exonucleases the joining of damaged ends may lead 
to mutation4. The HR pathway operates in S/G2 phase of the cell cycle where it uses the unbroken replicated sister 
chromatids as a template to copy and repair the broken chromosome.
Interstrand Crosslinks (ICLs) in DNA are generated by cancer therapy drugs like cisplatin and mitomycin C 
(MMC). These drugs physically link the two DNA strands thereby interfering with gene transcription and DNA 
replication. This DNA damage is repaired by the ICL repair pathway which is achieved by combining activities 
from multiple repair pathways including helicase, nucleotide excision repair, homologous recombination and 
translesion synthesis (TLS)5,6. Post-translational modifications of repair proteins allow cells to tightly control 
the action and efficiency of repair machinery components to ensure efficient repair and avoid the propagation of 
damaged DNA.
The activity of DNA damage repair components has been shown to be under control of several types of post 
translational modification including phosphorylation and ubiquitination. Protein ubiquitination is critical for 
DNA double strand break (DSB) repair by homologous recombination7. Absence of protein polyubiquitination is 
observed after inactivation of several ubiquitin E3 ligases such as Rnf8, Rnf168 and Brca1 which correlates with a 
failure to properly repair the DSB by homologous recombination, ultimately leading to several human syndromes 
or cancer. Cells from Fanconi anemia (FA) patients are hypersensitive to ICL damage8,9. The FA core complex 
promotes monoubiquitination of FancI and FancD2 which facilitates ICL repair by recruitment of downstream 
factors like nucleases, to the site of DNA damage10–15.
Recently, Small Ubiquitin Modifier (SUMO) has been shown to play a role in the response of cells to DNA 
damage16–19. The core enzymatic cascade that mediates protein SUMOylation is conserved in all eukaryotes. In 
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humans, there are three SUMO paralogues, SUMO1, SUMO2 and SUMO3 that can be linked to the side chains 
of lysine residues in target proteins. The SUMOylation consensus site Ψ Kx(D,E) (Ψ : hydrophobic amino acid, 
X: any aminoacid) is found in SUMO2/3 but not SUMO1 which allows the formation of chains of SUMO2/3 
(polySUMO). SUMOylation is involved in for many cellular processes including protein stability, protein inter-
action, activity and localization20. Mutation or altered regulation of enzymes essential for protein SUMOylation 
have been implicated in cancer, heart disease, virus infection and diabetes21–23. Rnf4 is a RING type E3 ubiquitin 
ligase which contains four SUMO interaction motifs in its N-terminal region that allow the protein to interact 
with SUMO chains and drive their ubiquitination24. Recent work revealed that Rnf4 is essential for DNA damage 
repair of DSB by homologous recombination25,26. Together these observations suggest that Rnf4 is a key protein 
which allows the ubiquitination of SUMOylated protein targets after DNA damage and that ubiquitination and 
SUMOylation modification pathways are closely interconnected by Rnf4 to repair damaged DNA.
To promote ubiquitination upon DNA damage, the ubiquitin E3 ligase Rnf4 must associate with its cog-
nate ubiquitin E2 conjugating enzyme. Ube2w is an unusual E2 enzyme that catalyses N-terminal monoubiq-
uitination of target proteins in vitro27,28. Recent work revealed that Ube2w can functionally interact with Rnf4 
to promote N-terminal mono-ubiquitination of SUMO chains in vitro27. Monoubiquitinated SUMO chains can 
be further modified by the heterodimeric E2 conjugating enzyme Ubc13/Uev1 to form K63 linked ubiquitin 
chains27. K63-ubiquitin chains formed by the Ubc13 complex are important for DNA damage repair by homol-
ogous recombination. In DNA damaged cells that are depleted of Rnf4, the levels of K63 ubiquitin chains are 
reduced25. Ube2w has also been shown to allow anchoring of K63 ubiquitin chains on internal lysine of Trim5α 
during restriction of HIV reverse transcription29. Together these observations suggest that Ube2w and Rnf4 may 
work together to promotes K63 ubiquitin chain formation upon DNA damage.
Here we show that cells lacking Rnf4 but not Ube2w are hypersensitive to replication stress, inter strand DNA 
crosslinking agents and DSB caused by γ -irradiation. In contrast, cells lacking Ube2w are not hypersensitive to 
the DNA damaging agents tested, but inactivation of Ube2w in Δ RNF4 mutant cells rescues the DNA damage 
sensitivity. These data indicate that Ube2w does not have an essential role in the DNA damage response, but is 
deleterious in the absence of Rnf4. Thus, while Rnf4 and Ube2w functionally interact in vitro, these genetic exper-
iments suggest that in response to DNA damage Ube2w and Rnf4 function in distinct pathways.
Results
Ube2w inactivation suppresses ΔRNF4 hypersensitivity to DNA damage inducing drugs. In 
human cells, the role of Rnf4 in DSB repair by HR, NHEJ and ICL repair has been previously described25,26,30. In 
DT40 cells, a role for Rnf4 in DNA damage repair was observed in replication associated stress25. As an ubiquitin 
E3 ligase Rnf4 must work in DNA repair with the help of an ubiquitin E2. The ubiquitin E2 Ube2w has been 
shown to promote monoubiquitination of SUMO chains in an Rnf4 dependent manner in vitro27.
To study the role of Ube2w and Rnf4 in DNA damage repair at the genetic level, we created chicken DT40 cell 
lines deleted for RNF4 (Δ RNF4); UBE2W (Δ UBE2W) and the double deletion Δ RNF4 Δ UBE2W (Fig. 1a). The 
three cell lines were viable and proliferated at similar rates as the wild type cell line. We subjected each cell line to 
DNA damage inducing drugs and measured the cell survival rate by colony formation assay. As observed before, 
Δ RNF4 cells were hypersensitive to replication stress caused by hydroxyurea (HU) exposure (Fig. 1b). Δ UBE2W 
Figure 1. Ube2w inactivation rescues ΔRNF4 replication stress hypersensitivity. (a) Whole cells extracts of 
Chicken DT40 wild type cells and cells deficient for Rnf4 (Δ RNF4), Ube2w (Δ UBE2W) and Rnf4 and Ube2w 
(Δ RNF4, Δ UBE2W) were analysed by western blotting using the indicated antibodies. 3 ng of recombinantly 
expressed rat Rnf4 and Human Ube2w isoform1 protein were used as a control. Molecular weight markers 
(kDa) are indicated on the right. (b) Wild type cells and cells deficient for Δ RNF4; Δ UBE2W and Δ RNF4, Δ 
UBE2W were subjected to replication stress by HU. The concentration of HU is indicated on the X-axis (μ M). 
Effect on each cell line is indicated by the percentage of colony formation on the Y-axis (logarithmic scale). 
Error bars represent two standard deviations from the mean (2SD).
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mutants showed no sensitivity to HU induced replication stress (Fig. 1b). Surprisingly, we observed that the 
double deletion cell line of Δ RNF4 Δ UBE2W was not hypersensitive to HU induced replication stress (Fig. 1b). 
These results showed that inactivation of Ube2w in a Δ RNF4 background rescued the HU-induced replication 
stress hypersensitivity observed in Δ RNF4 mutants, thus suggesting that Ube2w is deleterious in the absence of 
Rnf4 and that Ube2w and Rnf4 function in distinct pathways of DNA damage repair.
To confirm that the hypersensitivity to HU induced replication stress was due to Rnf4 deficiency and not 
caused by secondary mutation we expressed mCherry-Rnf4 in the Δ RNF4 cell line. Δ RNF4 hypersensitivity to 
HU was entirely complemented by the expression of chicken mCherry-Rnf4 (Fig. 2a and supplementary Fig. S1a). 
Similarly, to confirm the specific role of Ube2w in Δ RNF4 Δ UBE2W double mutant cells, we ectopically 
expressed human E2 Ube2w isoform 2 in these cells (Fig. 2b and supplementary Fig. S1c) and demonstrated 
that they regained the HU hypersensitivity of DT40 Δ RNF4 cells. Δ UBE2W mutant cells are not sensitive to 
HU, but overexpression of human E2 Ube2w in these cells induced a mild level of sensitivity to HU induced 
replication stress (supplementary Fig. S1b). We noted that tagged forms of Ube2w were unable to restore the HU 
hypersensitivity of Δ RNF4 Δ UBE2W cells suggesting that tagging Ube2w renders the protein inactive in vivo 
(supplementary Fig. S1g,h).
We next tested the sensitivity of Δ RNF4 mutant cells to other types of DNA damage. In addition to HU, Δ 
RNF4 cells are hypersensitive to ionising radiation, MMC and cisplatin (Fig. 3) and display mildly increased 
sensitivity to the DNA alkylating agent methyl methanesulfonate (MMS) (supplementary Fig. S2a). In each case 
the observed hypersensitivity is lost in Δ RNF4 Δ UBE2W cells (Fig. 3). Although Δ RNF4 cells are hypersensitive 
to the DNA polymerase inhibitor aphidicolin, this hypersensitivity was not rescued in Δ RNF4 Δ UBE2W cells 
(supplementary Fig. S2a). As observed for HU (Fig. 1) Δ UBE2W mutant cells are not hypersensitive to any of 
these agents (Fig. 3, supplementary Fig. S2a), although they do display a mild hypersensitivity to etoposide (sup-
plementary Fig. S2a). Thus Ube2w has only a limited non-redundant role in the DNA damage response.
Prolonged FancD2/I monoubiquitination induced by MMC in the absence of by Rnf4 is rescued 
by UBE2W inactivation. Cisplatin and MMC generate interstrand ICLs in DNA that are repaired by the 
ICL repair pathway. The Δ RNF4 mutant cell line is hypersensitive to the ICL inducing drugs MMC and cisplatin: 
at 50 ng/ml MMC, Δ RNF4 cells are greater than 200 fold more sensitive than wild type cells (Fig. 3). This extreme 
sensitivity to DNA cross linking agents is also observed in DT40 cells with mutations in FA pathway compo-
nents5. Thus to establish if the FA pathway is functional in Δ RNF4 cells we determined the levels of monoubiq-
uitinated FancI and FancD2 upon MMC treatment.
In response to a 60 minutes MMC treatment, the levels of both monoubiquinated FancI and FancD2 increase 
in all cell lines, reaching peak levels around 8–24 H after treatment (Fig. 4a). This indicates that the FA path-
way is activated in all of the mutant cell lines. To compare the efficiency and timing of ubiquitin modification 
of FancI and FancD2 in response to MMC in wild type and Δ RNF4, Δ UBE2W and Δ RNF4 Δ UBE2W cells, 
extracts were analysed by quantitative Western blotting (Fig. 4b,c and supplementary Fig. S3). It is known that 
24–48 H after treatment the decreased levels of monoubiquitinated FancI and FancD2 are a reflection of active 
ICL repair. Consistent with recent observations in human cells31 the monoubiquitinated form of FancI accumu-
lates to a higher level in response to MMC treatment in Δ RNF4 cells compared to wild type cells (Fig. 4b,c and 
Figure 2. Complementation of ΔRNF4 and ΔRNF4 ΔUBE2W mutant defects. (a) Wild type cells; Δ RNF4 
and Δ RNF4 cells complemented with chicken mCherry-Rnf4 as described in Fig. 1 were subjected to colony 
survival assay after treatment with the indicated concentration of HU. (b) Wild type cells; Δ RNF4; Δ RNF4 
Δ UBE2W and Δ RNF4 Δ UBE2W complemented with Human Ube2w isoform2 were subjected to colony 
survival assay with the indicated concentrations of HU. Data represented as indicated: Wild type (Blue losange), 
Δ RNF4 (red square), Δ RNF4 Δ UBE2W (green triangle), rescue clone (circle opal). Error bars represent 2 SD.
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supplementary Fig. S3). Levels of monoubiquitinated FancI were similar in wild type, Δ UBE2W and Δ RNF4 Δ 
UBE2W cells, indicating that the increased accumulation of monoubiquitinated FancI in Δ RNF4 cells was abro-
gated by codepletion of Ube2w (Fig. 4b,c and supplementary Fig. S3). In untreated cells the levels of monoubiq-
uitinated FancD2 were similar in all cell types as was the rate of accumulation of monoubiquitinated FancD2 in 
response to MMC (Fig. 4b,c and supplementary Fig. S3).
Prolonged DNA damage induced foci formation in ΔRNF4 cells is suppressed by UBE2W inac-
tivation. Sustained monoubiquitination of FancI in response to MMC in Δ RNF4 cells compared to wild type 
levels of monoubiquitinated FancI in Δ RNF4 Δ UBE2W cells suggests that a late step in the repair pathway is 
defective in the absence of Rnf4 when Ube2w is present, but this pathway is restored when Rnf4 and Ube2w are 
codepleted. Following activation of the FA pathway, the assembly and disassembly of Rad51 filaments is a key 
step in the repair of ICL DNA damage. We therefore assessed the formation of Rad51 foci as readout for a late 
step in the repair of damaged DNA. As an early marker of DNA damage we co-stained with γ -H2ax. Cells were 
either untreated or treated with MMC for 60 minutes and then fixed and stained after 4 or 16H. Quantification of 
the number of γ -H2ax and Rad51 foci per nucleus over time provides a read out of DNA repair. Untreated wild 
type and mutant cells exhibit only a few γ -H2ax and Rad51 foci (Fig. 4a–c), but after MMC treatment, all cells 
lines displayed an increased number of γ -H2ax and Rad51 foci per nucleus. 16H after DNA damage, more than 
a third of the wild type, Δ UBE2W and Δ RNF4 Δ UBE2W cells had no γ -H2ax or Rad51 foci suggesting that 
the DNA damage is repaired in these cells (Fig. 5a–c and supplementary Fig. S4). However, in Δ RNF4 cells 16H 
after recovery, more than 90% of cells show a large number of large γ -H2ax and Rad51 foci, suggesting that ICL 
DNA repair foci are not resolved efficiently in Δ RNF4 cells. Δ RNF4 Δ UBE2W cells have a similar number of 
γ -H2ax and Rad51 foci per nucleus as wild type cells indicating that the repair defect in Δ RNF4 cells is rescued by 
Figure 3. Ube2w inactivation suppressed ΔRNF4 DNA damaged hypersensitivity. Wild type cells and cells 
deficient for Δ RNF4, Δ UBE2W and Δ RNF4 Δ UBE2W were subjected to DNA damaged induced stress by 
mitomycin C, cisplatin, γ -irradiation, HU as indicated. X-axis indicated the increase range of concentration for 
each drug. Effect on each cell line is indicated of the percentage of colony formation on the Y-axis (logarithmic 
scale). DATA represented as indicated: Wild type (Blue losange), Δ RNF4 (red square), Δ UBE2W (brown 
circle), Δ RNF4 Δ UBE2W (green triangle). Error bars represent 2 SD.
www.nature.com/scientificreports/
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inactivation of E2 Ube2w. This indicates that in the absence of Rnf4, the presence of Ube2w results in a late stage 
defect in the repair of damaged DNA.
The deleterious effect of Ube2w in the absence of Rnf4 is conserved in human cells. To analyse 
the genetic interactions between Ube2w and Rnf4 in the DNA damage response of human cells CRISPR/Cas9 
technology was used to generate Δ RNF4, Δ UBE2W and Δ RNF4 Δ UBE2W cells (Fig. 6a) These cell lines were 
treated with DNA damaging drugs and cell survival determined by clonogenic survival assays. Δ RNF4 cells were 
hypersensitive to hydroxyurea (Fig. 6b), although the defects observed were less pronounced than in chicken 
cells. As observed in chicken cells, the defect caused by depletion of Rnf4 is rescued by codepletion of Ube2w. 
Δ UBE2W cells were not sensitised to DNA damage (Fig. 6b). These results suggest that the deleterious effect of 
Ube2w in the absence of Rnf4 is conserved in human cells and that Ube2w and Rnf4 function in distinct pathways 
of DNA repair.
Discussion
The role of the ubiquitin E2 conjugating enzyme Ube2w has been rather elusive. While the ubiquitin E2 conju-
gating enzyme Ube2T has been shown to functionally interacts with the FancL E3 ligase to mono-ubiquitinate 
FancI and FancD2 in response to ICL32,33,Ube2w was reported to promote monoubiquitination of FancD2 upon 
UV damage34. An in vitro study showed that Ube2w can promote monoubiquitination on FancD2 also in the 
absence of E3 ligase FancL11. Critically, in vivo studies of Ube2w/Ubc16 in several organisms failed to identify 
a role in DNA damage34–36. In agreement with these observations we have found that Δ UBE2W cells are not 
sensitised to any of the DNA damaging agents tested. This is also consistent with data from a high throughput 
siRNA screen assessing the role of all known E2 conjugating enzymes in the DNA damage response. Knockdown 
of Ube2w did not lead to a major defect in repair efficiency and did not alter the number of foci per cell staining 
with 53BP1 and γ -H2ax, although there was a 50% reduction in the number of foci per cell that stained with the 
anti-ubiquitin antibody FK237. Using a genetic approach in chicken DT40 cells we could show that in the absence 
Figure 4. Increased and prolonged FancD2/I monoubiquitination induced by MMC in ΔRNF4 is rescued 
by UBE2W inactivation. Wild type cells and cells deficient for Δ RNF4, Δ UBE2W and Δ RNF4 Δ UBE2W were 
treated with MMC (100ng/ml) for 1H. (a) Proteins were analysed by western blot using antibodies against FancI 
(top panel) and FancD2 (bottom panel). The recovery time after MMC treatment of each protein extraction 
is indicated on each lane of the top panel in hours. Non-ubiquitinated and mono-ubiquitinated form of FancI 
and FancD2 are indicated by an arrows head on the left inside (respectively: I> , D2> and I-Ub> ; D2-Ub> ). 
Asterisk indicates non specific band (*). Molecular weight markers are indicated on the right inside (kDa). (b,c) 
quantification of the ratio of ubiquitinated protein to total protein has been determined by three independent 
LiCOR experiment for FancI and FancD2. LiCOR images can be seen in supplementary Fig. S3.
www.nature.com/scientificreports/
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of Rnf4 the presence of Ube2w has a deleterious effect on cell survival in response to a range of DNA damaging 
agents. The precise molecular explanation for this observation has not been established but one possibility is that 
in combination with an E3 ligase other than Rnf4, Ube2w monoubiquitinates a substrate or substrates in response 
to DNA damage that acts to prime the substrate for the Rnf4 mediated synthesis of K63 ubiquitin chains that may 
create a platform for the action of effector molecules. In the absence of Rnf4 the normally transient, monoubiq-
uitinated intermediate created by Ube2w would accumulate and its failure to be further ubiquitinated might block 
a downstream step in DNA repair. As Δ UBE2W cells are not hypersensitive to DNA damaging agents the mon-
oubiquitination mediated by Ube2w must be redundant and in the absence of Ube2w this modification could be 
carried out by another E2 ubiquitin conjugating enzyme. In fact it is known that Ube2w can work with multiple 
E3 ligases and could generate monoubiquitinated substrates in combination with Brca138. Likewise Rnf4 has been 
shown to functionally interact with multiple ubiquitin E2 conjugating enzymes including Ube2w, Ubc13/Uev1 
and UbcH527. Identification of targets for Ube2w mediated monoubiquitination in cells lacking Rnf4 is chal-
lenging but would represent a major step forward in understanding the deleterious role of Ube2w in the absence 
Figure 5. Prolonged DNA damage induced foci formation in ΔRNF4 cells is suppressed by UBE2W 
inactivation. After treatments with or without MMC (50ng/ml) for 1H, cells were allowed to recover for 4H 
or 16H. (a) For each indicated cell line, the formation of MMC induced foci for γ -H2ax (green) and Rad51 
(red) was analysed by immunostaining. Chromatin was visualized by DAPI (Blue). Representative images are 
shown for each staining and merged images. White bar: 10 um. (b,c) percentage of cell containing no focus; 
1–5 foci; >5 foci are represented for each conditions respectively in blue, red and yellow. (a) γ -H2ax. (b) Rad51 
quantification. More than 100 cells have been counted for each condition.
www.nature.com/scientificreports/
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of Rnf4. Hypersensitivity to cisplatin in Fanconi anemia mutant ceIls caused by a failure to repair interstrand 
crosslinks can be suppressed by inactivating the NHEJ pathway39,40. Therefore the suppression of DNA damage 
hypersensitivity in Δ RNF4 by the inactivation of Ube2w could be explained if Ube2w would be a component of 
NHEJ pathway. SUMO modification of FancI and FancD2 has been shown to allow recruitment of Rnf4, leading 
to polyubiquitination of FancI and FancD2 and their removal by the Dvc1-p97 segregase31. Early work suggested 
that Ube2w can promote monoubiquitination of FancD2 upon UV treatment and Ube2w interact with FancL at 
DNA damage repair foci34. However, these experiments have been carried out by using tagged versions of Ube2w 
which in our hands were non functional in vivo34. We observed an increase in monoubiquitination of FancI/D2 
upon MMC treatment in Δ RNF4 cells which is suppressed by the inactivation of Δ UBE2W. The role of Ube2w in 
Figure 6. Suppression of ΔRNF4 DNA damage hypersensitivity by ΔUBE2W is conserved in Human.  
(a,c) Whole cells extracts of Human HCT116 wild type cells and cells deficient for Rnf4 (Δ RNF4), Ube2w  
(Δ UBE2W) and Rnf4 and Ube2w (Δ RNF4 Δ UBE2W) were analysed by Western blotting using the indicated 
antibodies. 3 ng of recombinantly expressed rat Rnf4 and Human Ube2w isoform1 protein were used as a 
control. Molecular weight marker is indicated on the right inside (kDa). (b) Wild type cells and cells deficient 
for Δ RNF4; Δ UBE2W and Δ RNF4, Δ UBE2W were subjected to cisplatin, mitomycin C, γ -irradiation and 
replication stress by HU. The concentration of HU is indicated on the X-axis. Effect on each cell line is indicated 
of the percentage of colony formation on the Y-axis (logarithmic scale). Data represented as indicated: Wild 
type (Blue losange), Δ RNF4 (red square), Δ UBE2W (brown circle), Δ RNF4 Δ UBE2W (green triangle). Error 
bars represent 2 SD.
www.nature.com/scientificreports/
8Scientific RepoRts | 6:26178 | DOI: 10.1038/srep26178
this process is unclear but taken together these observations suggest that the control of post translational modifi-
cation of FancI/D2 is a critical step controlled by Rnf4 and Ube2w.
It is possible that the increase in monoubiquitination of FancI/D2 observed in Δ RNF4 is due to the lack of 
efficient DNA repair in these cells. Indeed, we could observe in Δ RNF4 cells upon MMC treatment an increased 
level of Rad51 foci formation which is an indication of repair delay or failure after ICL damage. However, Rnf4 
inactivation in human cells by siRNA leads to a reduction of Rad51 recruitment after DNA double strand 
break25,26. This discrepancy in observations can be explained by differences in the regulation of DNA repair path-
ways in different cell lines. Chicken DT40 cells have a rapid cell cycle with an extended S-phase that favours 
homologous recombination, whereas the predominant repair pathway in most human cells is NHEJ. Thus Rnf4 
may act on several targets at different stages on the same pathway as suggested by Yin et al.25. We observed an 
increased recruitment of Rad51 after ICL damage which is a different type of DNA damage from that studied 
in Yin et al.25. It is possible that Rad51 has a different role and regulation in these two types of DNA damage. A 
recent study of a Rad51 dominant mutant revealed its function in ICL repair independently of HR repair41. This 
suggests that Rad51 and its regulators are potential targets for Rnf4 and Ube2w to control DNA repair.
Ube2w is ubiquitously expressed in tissues and cells at variable levels35,36. The highest expression level of 
Ube2w is found in prostate, breast and lung cell lines35,36. This enzyme has been identified only in higher eukary-
otes34. In human and mouse, three isoforms have been described with variable N-terminal and C-terminal exten-
sions due to alternative splicing (NCBI). A recent study has shown that the flexible C-terminus of Ube2w is 
involved in dimerisation and substrate specificty42,43. It is thus possible that different isoforms of Ube2w have dif-
ferent activities although this has not been tested. Ube2w isoform one mediates N-terminal monoubiquitination 
in vitro27,28. However, in cells, the N-terminus of most proteins is processed and post translationally acetylated. As 
this would block N-terminal ubiquitination by Ube2w, substrates for N-terminal ubiquitination by Ube2w would 
have to be created by proteolitic cleavage or de novo protein synthesis. A recent study shows that in the case of 
Trim5α, Ube2w modifies a lysine side chain to prime the synthesis of K63-linked ubiquitin chain in vivo rather 
than promoting N-terminal mono-ubiquitination29. Identifying the target and each Ube2w isoform activity upon 
DNA damage treatment is a crucial but challenging step in order to understand the molecular mode of action of 
Ube2w.
In summary this work reveals for the first time that depletion of Rnf4 unmasks a deleterious action of Ube2w 
in DNA damage repair pathway after ICL, alkylated DNA damage and replication stress and suggests that Ube2w 
and Rnf4 function in distinct pathways of DNA repair.
Materials and Methods
Generation of RNF4−/− and UBE2W-/-/- cell lines. The scheme for the generation of the UBE2W 
gene disruption is outlined in (supplementary Fig. S5). Note, in DT40 cells the UBE2W locus is on the trisomic 
chromosome II. The targeting construct for UBE2W disruption was generated by amplifying the 5′ homology 
arm using DT40 genomic DNA as a template and the PCR primer pair 5′ GCAAAATGAT CCACCTCCCG 
GAATGAC and 5′ GGAATATTGT CACCAGTAAA CATGACC, and cloned into pCR2.1 using the TOPO TA 
cloning kit (Invitrogen). The 5′ arm was recovered as a NotI/BamHI fragment and cloned into a pBluescript vector 
to generate pBS-UBE2W5′ arm. The 3′ homology arm was amplified using the primer pair 5′ GTAAGGCAGG 
ATGGGAGGGA CAGAGTTAG and 5′ GCAGCAAGTT CAGTTATATC ACTGCCATCC, cloned into pCR2.1, 
recovered as BamHI/EcoRV fragment and cloned into pBS-UBE2W5′ arm. The puromycin (first allele), blasti-
cidin (second allele) and histidinol (third allele) resistance cassettes were inserted into the BamHI restriction 
site. Targeted integrations were detected by Southern blot analysis of BamHI/KpnI-digested genomic DNA. 
Generation of RNF4 knock out has been described previously25.
CRISPR/Cas9 knock out. Gene knock out in human cell using CRISPR/Cas9 technology has been 
described previously44,45. Shortly, humanized Cas9 wild type (Addgene 42229/ pX260) or nickase Cas9-D10A 
(Addgene 42333/ pX334) combined with gRNA targetting vector were transfected into cells using GeneJuice 
(Millipore). Each targeting protospacer for human RNF4 and UBE2W were introduced by direct PCR mutagen-
esis into pA608 (pA608 is modified version of Addgene 41824 guide RNA cloning vector). The sequence used to 
target Human RNF4 gene is “gacgctttctctgagtagca” (pA622) and “gctactcagagaaagcgtcg” (pA624). The sequence 
used to target Human UBE2W gene is “gttccatcatggcgtcaatgc” (pA629).
Plasmids for complementation. pCMV-mCherry-ggRNF4 (pA626): Gallus gallus Rnf4 (NP_001012907.1, 
NCBI) containing the polymorphism (G169 > D169) was cloned from DT40 cDNA into a modified version of 
pCMV-mCherry-C1 (Clontech) were a chicken hygromycin resistance cassette was inserted into BamH1 site.
pCAG-hUBE2W isoF2 (pA670). Human Ube2w (NCBI NP_060769.4/ (M30-C151) was subcloned into 
home made vector under CAG promoter containing chicken Hygromycin resistance cassette.
pCMV-hUBE2W isoF1 (pA631). Human Ube2w (NCBI NP_001001481.2/ (M30-C162) was subcloned 
into pCMV-EGFP/G418 vector (clonTech).
Expression of recombinant protein. Gallus gallus Rnf4 (NP_001012907.1, NCBI) containing the poly-
morphism (G169 > D169) was cloned from DT40 cDNA into pLou3 in order to express HIS6-MBP-TEV-ggRnf4 
(pA612). Technical purification detail has been described previously24. Briefly, ggRnf4 was expressed in BL21 
Rosetta 2 and purified on Nickel column. The tag was cleaved off by TEV protease. Rattus norvegicus Rnf4 and 
homo sapiens Ube2w purification were described before24,27.
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Antibody affinity purification. The procedure was described previously24. Briefly, 30mg of dialysed recom-
binant protein untagged HsUbe2w (or ggRnf4) were covalently bound to activated NHS sepharose beads. 5ml of 
each sheep serum pass onto the affinity column. Bound antibodies were eluted with 0.1M glycine.
Cell culture. DT40 cell transfections and culture were described previously25,46,47. Antibiotics used were 
Puromycin (0.5 μ g/ml); Hygromycin (2 mg/ml, Roche 10843555001); Blasticidin (20 μ g/ml, Melford B1105); 
Histidinol (1 mg/ml, SIGMA H6647-3G), G418 (2 mg/ml, Calbiochem 345812) in RPMI-1640 (Gibco/Invitrogen 
3187-025)
Protein Extraction for western blotting and LiCOR. Twenty million cells of each cell line were col-
lected by centrifugation and wash with PBS 1X. Cells were resuspended in Lysis buffer (20 mM Tris pH7.5; 
150 mM NaCl; 0.5% NP40; 50 mM β-glycerophosphate; 50 mM NaF; 2 mM NaVo4, Complete protease inhibitor 
Roche tablet) for 10 minutes. Lysates were centrifuged for ten minutes at 14000 g/4 °C. Supernatants were col-
lected and sample buffer added prior to boiling. 50 μ g of protein were separating by SDS-PAGE. Proteins were 
transferred onto PVDF membrane (Immubilon-P; 0.45 μ m) for western blot detection. Proteins were transferred 
onto nitrocellulose membrane for LiCOR detection. Antibodies uses in this study are described in Supplementary 
Table1. FancI/D2 protein extraction and detection were described previously in46.
Immunofluorescence. DT40 cells were attached for 20 minutes onto coverslip pretreated with 0.2% 
Concanavalin A (SIGMA: C7275). Cells were pre-extracted with 0.2% PBS triton for two minutes at 37 °C before 
seven minutes of fixation with 4% PFA. Cells were then processes for immunofluorescence as described previ-
ously in25.
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